Igg Antibody And Herpes
Lab Reagents
Igg Antibody Laboratories manufactures the igg antibody and herpes reagents distributed by Genprice. The Igg Antibody And Herpes reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igg antibody. Other Igg products are available in stock. Specificity: Igg Category: Antibody Group: And Herpes
Herpes Simplex Virus 1 and 2 (HSV1/HSV2) Antibody (HRP) |
|||
abx411408-1ml | Abbexa | 1 ml | 760.8 EUR |
ELISA kit for Human herpes simplexvirus Ⅰ (HSVⅠ) antibody (IgG) |
|||
EK0225 | SAB | 96 tests | 854.4 EUR |
Description: Enzyme-linked immunosorbent assay kit for quantification of Human herpes simplexvirus Ⅰ (HSVⅠ) antibody (IgG) in samples from serum, plasma, tissue homogenates and other biological fluids. |
|||
Herpes Virus 8 Antibody |
|||
V8306-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: HHV 8 encodes a latent nuclear antigen (LNA), which is the product of the viral gene orf 73. LNA is capable of forming a complex with retinoblastoma susceptibility gene product, which may be related to its oncogenic activity. HHV8 is associated with three different diseases observed in AIDS patients; kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. HHV 8 is the likely etiological agent of Kaposis sarcoma. |
|||
Herpes Virus 8 Antibody |
|||
V8306-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: HHV 8 encodes a latent nuclear antigen (LNA), which is the product of the viral gene orf 73. LNA is capable of forming a complex with retinoblastoma susceptibility gene product, which may be related to its oncogenic activity. HHV8 is associated with three different diseases observed in AIDS patients; kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. HHV 8 is the likely etiological agent of Kaposis sarcoma. |
|||
Herpes Virus 8 Antibody |
|||
V8306SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: HHV 8 encodes a latent nuclear antigen (LNA), which is the product of the viral gene orf 73. LNA is capable of forming a complex with retinoblastoma susceptibility gene product, which may be related to its oncogenic activity. HHV8 is associated with three different diseases observed in AIDS patients; kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. HHV 8 is the likely etiological agent of Kaposis sarcoma. |
|||
Herpes Virus 8 Antibody |
|||
V8345-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: HHV 8 encodes a latent nuclear antigen (LNA), which is the product of the viral gene orf 73. LNA is capable of forming a complex with retinoblastoma susceptibility gene product, which may be related to its oncogenic activity. HHV8 is associated with three different diseases observed in AIDS patients; kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. HHV 8 is the likely etiological agent of Kaposis sarcoma. |
|||
Herpes Virus 8 Antibody |
|||
V8345-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: HHV 8 encodes a latent nuclear antigen (LNA), which is the product of the viral gene orf 73. LNA is capable of forming a complex with retinoblastoma susceptibility gene product, which may be related to its oncogenic activity. HHV8 is associated with three different diseases observed in AIDS patients; kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. HHV 8 is the likely etiological agent of Kaposis sarcoma. |
|||
Herpes Virus 8 Antibody |
|||
V8345SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: HHV 8 encodes a latent nuclear antigen (LNA), which is the product of the viral gene orf 73. LNA is capable of forming a complex with retinoblastoma susceptibility gene product, which may be related to its oncogenic activity. HHV8 is associated with three different diseases observed in AIDS patients; kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. HHV 8 is the likely etiological agent of Kaposis sarcoma. |
|||
Bovine Immunoglobulin G (IgG) ELISA Kit |
|||
DLR-IgG-b-48T | DL Develop | 48T | 547.2 EUR |
Description: A competitive inhibition quantitative ELISA assay kit for detection of Bovine Immunoglobulin G (IgG) in samples from serum, plasma or other biological fluids. |
|||
Bovine Immunoglobulin G (IgG) ELISA Kit |
|||
DLR-IgG-b-96T | DL Develop | 96T | 708 EUR |
Description: A competitive inhibition quantitative ELISA assay kit for detection of Bovine Immunoglobulin G (IgG) in samples from serum, plasma or other biological fluids. |
|||
Canine Immunoglobulin G (IgG) ELISA Kit |
|||
DLR-IgG-c-48T | DL Develop | 48T | 529.2 EUR |
Description: A competitive inhibition quantitative ELISA assay kit for detection of Canine Immunoglobulin G (IgG) in samples from serum, plasma or other biological fluids. |
|||
Canine Immunoglobulin G (IgG) ELISA Kit |
|||
DLR-IgG-c-96T | DL Develop | 96T | 684 EUR |
Description: A competitive inhibition quantitative ELISA assay kit for detection of Canine Immunoglobulin G (IgG) in samples from serum, plasma or other biological fluids. |
|||
Equine Immunoglobulin G (IgG) ELISA Kit |
|||
DLR-IgG-Eq-48T | DL Develop | 48T | 432 EUR |
Description: A competitive inhibition quantitative ELISA assay kit for detection of Equine Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
|||
Equine Immunoglobulin G (IgG) ELISA Kit |
|||
DLR-IgG-Eq-96T | DL Develop | 96T | 548.4 EUR |
Description: A competitive inhibition quantitative ELISA assay kit for detection of Equine Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
|||
Goat Immunoglobulin G (IgG) ELISA Kit |
|||
DLR-IgG-g-48T | DL Develop | 48T | 556.8 EUR |
Description: A competitive inhibition quantitative ELISA assay kit for detection of Goat Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
|||
Goat Immunoglobulin G (IgG) ELISA Kit |
|||
DLR-IgG-g-96T | DL Develop | 96T | 721.2 EUR |
Description: A competitive inhibition quantitative ELISA assay kit for detection of Goat Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
|||
Human Immunoglobulin G (IgG) ELISA Kit |
|||
DLR-IgG-Hu-48T | DL Develop | 48T | 286.8 EUR |
Description: A competitive inhibition quantitative ELISA assay kit for detection of Human Immunoglobulin G (IgG) in samples from serum, plasma or other biological fluids. |